NCT05263947
- Conditions
- Bevacizumab, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Clinical trial condition
Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.
NCT05263947
NCT03724331
NCT02523469
NCT07050472
NCT06575933
NCT04384146
NCT05577702
NCT02917993
NCT04809103